List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 4549 studies with search of:   "Carcinoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
Conditions: Carcinoma, Squamous Cell;   Carcinoma, Adenosquamous;   Carcinoma, Large Cell;   Carcinoma, Non-Small-Cell Lung
Interventions: Drug: CP-751,871 + Carboplatin +Paclitaxel;   Drug: Carboplatin + Paclitaxel
2 Active, not recruiting RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
Conditions: Neuroendocrine Carcinoma;   Islet Cell Carcinoma
Interventions: Drug: RAD001;   Drug: Octreotide Depot
3 Withdrawn Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
Conditions: Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: capecitabine;   Procedure: adjuvant therapy;   Procedure: chemotherapy
4 Recruiting Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma;   Metastatic Hepatocellular Carcinoma
Intervention: Drug: Sorafenib with Capecitabine and Oxaliplatin
5 Completed Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma;   Carcinoma of Head and/or Neck
Interventions: Drug: Taxotere;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin
6 Recruiting Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab in Adult Patients With Kidney Cancer
Conditions: Carcinoma, Renal Cell;   Adenocarcinoma, Renal Cell;   Nephroid Carcinoma;   Carcinoma, Hypernephroid
Intervention: Drug: bevacizumab plus RAD001(Everolimus) versus bevacizumab and interferon alfa-2a
7 Terminated Two Studies to Determine If Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
Conditions: Basal Cell Carcinoma;   Nevoid Basal Cell Carcinoma Syndrome;   Gorlin Syndrome
Intervention: Drug: verteporfin PDT
8 Completed Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Advanced Squamous Cell Carcinoma;   Squamous Cell Carcinoma of Head and Neck;   SSCHN
Interventions: Drug: Docetaxel;   Drug: Cisplatin;   Drug: 5-Fluorouracil
9 Completed Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma;   Carcinoma of Head/Neck
Interventions: Drug: Taxotere;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: G-CSF;   Drug: Ciprofloxacin
10 Completed Celecoxib/Oxaliplatin/Capecitabine for Gastric/GE Junction Carcinoma
Conditions: Gastric Carcinoma;   Gastroesophageal Junction Carcinoma
Interventions: Drug: Oxaliplatin;   Drug: Capecitabine;   Drug: Celecoxib
11 Suspended Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor
Conditions: Primary Advanced Carcinoma of the Oral Cavity or Oropharynx;   Squamous Cell Carcinoma of the Head and Neck
Intervention: Biological: autologous monocyte-derived dendritic cells (DC) transfected with DNA
12 Recruiting Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma
Conditions: Recurrent Colorectal Carcinoma;   Progressive Colorectal Carcinoma
Interventions: Biological: Safety and efficacy of escalating doses;   Biological: Safety and efficacy of escalating doses.
13 Recruiting PRISM (Panitumumab Regimen In Second-Line Monotherapy of Head and Neck Cancer)
Conditions: Cancer;   Carcinoma;   Head and Neck Cancer;   Metastases;   Metastatic Cancer;   Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck;   Oncology;   Squamous Cell Carcinoma;   Tumors
Intervention: Drug: Panitumumab
14 Recruiting Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Conditions: Carcinoma, Giant Cell;   Carcinoma, Non-Small-Cell Lung
Intervention:
15 Withdrawn Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
Conditions: Merkel Cell Carcinoma;   Islet Cell Carcinoma;   Neuroendocrine Carcinoma;   Pituitary Tumor
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1;   Procedure: alternative product therapy;   Procedure: biological therapy;   Procedure: biologically based therapies;   Procedure: cancer prevention intervention;   Procedure: complementary and alternative therapy;   Procedure: differentiation therapy
16 Recruiting The Impact of Total Body Skin Examination on Skin Cancer Detection
Conditions: Melanoma;   Basal Cell Carcinoma;   Squamous Cell Carcinoma;   Merkel Cell Carcinoma;   Skin Cancer
Intervention: Other: skin cancer detection rate (Total Body Skin Examination)
17 Completed Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
Conditions: Carcinoma of Unknown Primary;   Neuroendocrine Carcinoma;   Neuroendocrine Carcinoma of the Skin
Intervention: Drug: irinotecan hydrochloride
18 Completed ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer
Conditions: Non-Small-Cell Lung Carcinoma;   Renal Cell Carcinoma;   Pancreatic Cancer
Intervention: Drug: ABR-217620
19 Not yet recruiting RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe
Conditions: Carcinoma;   Renal Cell;   Non Clear Cell Renal Carcinoma;   Papillary Cell Renal Carcinoma;   Adenocarcinoma
Intervention: Drug: Everolimus
20 Completed Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Conditions: Malignant Melanoma,;   Merkel Cell Carcinoma,;   Basal Cell Carcinoma,;   Squamous Cell Carcinoma;   Atypical Nevi,;   Congenital Nevi;   Seborrheic Keratosis,;   Paget's Disease;   Dermatofibroma,;   Kaposi's Sarcoma;   Hypervascular Congenital Malformations;   Port Wine Stain;   Hemangioma;   Tattoos;   Scleroderma;   Burns;   Normal Skin
Intervention: Device: OLCR,NIR/PMS,MI

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services